Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies

Background Mirabegron is a human β 3 -adrenoceptor agonist for the treatment of overactive bladder. The pharmacokinetic profile of mirabegron has been extensively characterized in healthy Caucasian subjects. Objective The objective of this study was to evaluate the pharmacokinetics, dose-proportiona...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical drug investigation 2014, Vol.34 (1), p.27-35
Hauptverfasser:	Iitsuka, Hiromi, Tokuno, Tomoaki, Amada, Yoko, Matsushima, Hiroshi, Katashima, Masataka, Sawamoto, Taiji, Takusagawa, Shin, van Gelderen, Marcel, Tanaka, Takanori, Miyahara, Hideo
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetanilides - administration & dosage Acetanilides - adverse effects Acetanilides - pharmacokinetics Adrenergic Agonists - administration & dosage Adrenergic Agonists - adverse effects Adrenergic Agonists - pharmacokinetics Adult Asian Continental Ancestry Group Dose-Response Relationship, Drug Healthy Volunteers Humans Internal Medicine Japan Male Medicine Medicine & Public Health Original Original Research Article Pharmacology/Toxicology Pharmacotherapy Single-Blind Method Thiazoles - administration & dosage Thiazoles - adverse effects Thiazoles - pharmacokinetics Urinary Bladder, Overactive - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!